Fidaxomicin

BNF:
5.1
Status:
Grey
Decision Date:
June 2019
 

Comments

GREY 2nd line for mild/moderate C. difficile infection. (Decision date - June 2022)

See NICE/PHE - Summary of antimicrobial prescribing guidance – managing common infections for further details.

Local C.Diff guideline 

Grey Drug Classifications

  • 6: NICE guidance

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app